Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiropramide vs Octylonium in IBS
NCT01629212Phase 4Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiropramide in irritable bowel syndrome (IBS), sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
tiropramide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01629212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629212.